Role of combining neutrophil-to-lymphocyte ratio and pretreatment body mass index in predicting progression-free survival in patients with non-small cell lung cancer treated with nivolumab

Identifying markers capable of predicting outcomes in lung cancer patients treated with nivolumab represents a growing research interest. The combination of neutrophil-to-lymphocyte ratio (NLR) and body mass index (BMI) may help predict treatment efficacy. Thus, the present study aimed to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dragomir, Radu, Dragomir, Adelina Silvana, Negru, Alina, Săftescu, Sorin, Popovici, Dorel, Schenker, Michael, Lupușoru, Raluca, Negru, Șerban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014982/
https://www.ncbi.nlm.nih.gov/pubmed/33815599
http://dx.doi.org/10.3892/etm.2021.9958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014982/
https://www.ncbi.nlm.nih.gov/pubmed/33815599
http://dx.doi.org/10.3892/etm.2021.9958

Ejemplares similares